Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117238 | SCV000151411 | benign | not specified | 2013-03-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001521057 | SCV000168829 | benign | not provided | 2019-04-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26981542, 29632382, 12669197, 20878384, 22995991, 15728204, 24503134, 24097065, 20981092, 10983627, 27884173, 27346685, 28008009, 26551672, 26105150, 24448600, 30297969, 25361053, 26503572) |
Prevention |
RCV000117238 | SCV000316593 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000280314 | SCV000433892 | likely benign | Familial hyperinsulinism | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000337755 | SCV000433893 | likely benign | Maturity-onset diabetes of the young type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Personalized Diabetes Medicine Program, |
RCV000445529 | SCV000537113 | benign | Monogenic diabetes | 2019-01-25 | criteria provided, single submitter | research | ACMG criteria: BA1 (Overall MAF in gnomAD 3%, 4.1% in European Finnish and 4.6% Latino), BS2 (549 cases and 492 controls in T2DM)= Benign (Note: ClinVar=benign with 2 stars, Chicago and GeneDx call it benign . BP4 not being used because REVEL 0.426, BP6 no longer applied) |
Laboratory for Molecular Medicine, |
RCV000117238 | SCV000539310 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 309/13006=2.3% |
Labcorp Genetics |
RCV001521057 | SCV001730311 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226673 | SCV002505502 | benign | Type 2 diabetes mellitus | criteria provided, single submitter | research | rs1800961, a loss-of-function mutation in HNF4A is associated with poor insulin secretion in response to hyperglycemia. These are associated with MODY1. Patients initially respond well to sulfonylureas but eventually become insulin dependent. This variant is also associated with increased risk of T2DM and periodontitis. | |
Ambry Genetics | RCV002453432 | SCV002614616 | benign | Maturity onset diabetes mellitus in young | 2015-07-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001521057 | SCV005208732 | likely benign | not provided | criteria provided, single submitter | not provided |